2015 Clinical Trials Epilepsy Patients 
MMJ Recs
DECEMBER 17, 2023
Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.
Peninsula Alternative Health
MAY 15, 2019
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 26, 2022
The designation is intended to accelerate the timeline for approval of innovative medicines for treatment of life-threatening conditions or those which present a significant patient or public health need. It is estimated that, in 2015, 3% of people in the UK were living with PTSD. Berra Yazar-Klosinski, Ph.D.
Cannabis Law Report
SEPTEMBER 6, 2021
The global medical cannabis market exhibited strong growth during 2015-2020. For instance, it is very effective in reducing nausea and increasing appetite among chemotherapy patients. 12 Overview of Clinical Research Suggesting the Benefits of Medical Cannabis Across Various Indications. during 2021-2026. Companies Mentioned.
Canna Care Docs
DECEMBER 16, 2020
The difference is that medical patients may have access to higher dosages, among other benefits depending on their state, and receive a higher level of service to match them with the best products for their symptoms. The following is a list of some, but not all, of the most common conditions and diseases it is used to treat. Chronic pain.
Peninsula Alternative Health
MAY 15, 2019
Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states. Because nearly one-third of patients with epilepsy are not getting the results they want from conventional treatments, they are eager to experiment with natural cannabinoid therapy.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.
Expert insights. Personalized for you.
52 
Let's personalize your content